Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122710415 | 12271041 | 5 | F | 20160906 | 20160415 | 20160907 | PER | US-TAKEDA-2016MPI002578 | TAKEDA | 0.00 | M | Y | 86.62000 | KG | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122710415 | 12271041 | 1 | PS | NINLARO | IXAZOMIB | 1 | Oral | 3 MG, UNK | U | 1402445 | 208462 | 3 | MG | CAPSULE | |||||
| 122710415 | 12271041 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122710415 | 12271041 | 1 | Plasma cell myeloma |
| 122710415 | 12271041 | 2 | Plasma cell myeloma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122710415 | 12271041 | Back pain | |
| 122710415 | 12271041 | Drug ineffective | |
| 122710415 | 12271041 | Epistaxis | |
| 122710415 | 12271041 | Fatigue | |
| 122710415 | 12271041 | Off label use | |
| 122710415 | 12271041 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122710415 | 12271041 | 1 | 20160314 | 0 |